Former FDA Commissioner David Kessler Discusses Agency Challenges
David Kessler, who previously led the Food and Drug Administration, offered comments on the agency's current condition and possible next steps. The remarks were shared during a STAT Breakthrough event.
thehindu.comThe comments were delivered as part of the STAT Breakthrough series.
Kessler described operational conditions at the agency and identified areas that may require attention. He presented these observations without specifying timelines or particular policy changes.
Kessler outlined possible approaches the agency could consider. The remarks focused on general principles rather than detailed proposals or named programs.
Key Facts
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…